Finnish biotechnology company developing precision RNA-based gene regulating therapies
RNatives has raised €1.4M across 1 funding round from 3 investors, most recently a Seed round in May 2025. Based in Kuopio, Finland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-27 | Seed | €1.4M |
| Business Finland,Force10,Nordic Science Investments (NSI) |
| View deal → |
